DK548081A - Fremgangsmaade til fremstilling af buspiron - Google Patents

Fremgangsmaade til fremstilling af buspiron

Info

Publication number
DK548081A
DK548081A DK548081A DK548081A DK548081A DK 548081 A DK548081 A DK 548081A DK 548081 A DK548081 A DK 548081A DK 548081 A DK548081 A DK 548081A DK 548081 A DK548081 A DK 548081A
Authority
DK
Denmark
Prior art keywords
buspiron
preparation
buspiron preparation
Prior art date
Application number
DK548081A
Other languages
English (en)
Other versions
DK154560C (da
DK154560B (da
Inventor
R R Covington
D L Temple
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK548081A publication Critical patent/DK548081A/da
Publication of DK154560B publication Critical patent/DK154560B/da
Application granted granted Critical
Publication of DK154560C publication Critical patent/DK154560C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK548081A 1980-12-11 1981-12-10 Fremgangsmaade til fremstilling af radioaktivt maerket 8-oe4-oe4-(2-pyrimidinyl)-1-piperazinylaabutylaa-8-azaspiro-oe4.5aadekan-7,9-dion DK154560C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21521480A 1980-12-11 1980-12-11
US21521480 1980-12-11

Publications (3)

Publication Number Publication Date
DK548081A true DK548081A (da) 1982-06-12
DK154560B DK154560B (da) 1988-11-28
DK154560C DK154560C (da) 1989-04-17

Family

ID=22802113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK548081A DK154560C (da) 1980-12-11 1981-12-10 Fremgangsmaade til fremstilling af radioaktivt maerket 8-oe4-oe4-(2-pyrimidinyl)-1-piperazinylaabutylaa-8-azaspiro-oe4.5aadekan-7,9-dion

Country Status (18)

Country Link
JP (1) JPS57122082A (da)
AT (1) AT380686B (da)
AU (1) AU528067B2 (da)
BE (1) BE891446A (da)
CA (1) CA1172255A (da)
CH (1) CH647518A5 (da)
DE (1) DE3149011A1 (da)
DK (1) DK154560C (da)
FI (1) FI73993C (da)
FR (1) FR2496105B1 (da)
GB (1) GB2089341B (da)
GR (1) GR76331B (da)
IE (1) IE51948B1 (da)
IT (1) IT1172073B (da)
LU (1) LU83833A1 (da)
NL (1) NL8105529A (da)
SE (1) SE444438B (da)
YU (1) YU42432B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212301B (en) * 1989-04-28 1996-05-28 Alkaloida Vegyeszeti Gyar Process for producing buspirone
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
KR950014099A (ko) * 1993-11-10 1995-06-15 장기하 N-(2-피리미딜)피페라지닐 부틸아미드의 제조방법
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
DE2341925A1 (de) * 1973-08-20 1975-03-06 Thomae Gmbh Dr K Neue pyrimidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FR2496105A1 (fr) 1982-06-18
YU243681A (en) 1984-02-29
FI73993B (fi) 1987-08-31
GB2089341B (en) 1984-09-19
GB2089341A (en) 1982-06-23
FR2496105B1 (fr) 1985-12-13
DE3149011C2 (da) 1988-08-25
JPH0113476B2 (da) 1989-03-06
SE444438B (sv) 1986-04-14
SE8107446L (sv) 1982-06-12
GR76331B (da) 1984-08-04
CH647518A5 (de) 1985-01-31
FI813937L (fi) 1982-06-12
IE812897L (en) 1982-06-11
DK154560C (da) 1989-04-17
AU528067B2 (en) 1983-04-14
IT1172073B (it) 1987-06-18
NL8105529A (nl) 1982-07-01
IT8149718A0 (it) 1981-11-16
CA1172255A (en) 1984-08-07
DK154560B (da) 1988-11-28
BE891446A (fr) 1982-06-11
JPS57122082A (en) 1982-07-29
AT380686B (de) 1986-06-25
FI73993C (fi) 1987-12-10
IE51948B1 (en) 1987-04-29
YU42432B (en) 1988-08-31
LU83833A1 (fr) 1982-07-07
AU7604181A (en) 1982-07-15
ATA529581A (de) 1985-11-15
DE3149011A1 (de) 1982-07-15

Similar Documents

Publication Publication Date Title
DK350083A (da) Fremgangsmaade til fremstilling af phenylethanolaminer
DK434381A (da) Fremgangsmaade til fremstilling af substituerede imonodicarboxylsyrer
DK417981A (da) Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater
DK88081A (da) Fremgangsmaade til fremstilling af tetrazolderivater
DK319281A (da) Femgangsmaade til fremstilling af benzisoselenazoloner
DK156253C (da) Fremgangsmaade til fremstilling af pyruvatoxidase
DK582883D0 (da) Fremgangsmaade til fremstilling af modelis
DK212381A (da) Fremgangsmaade til fremstilling af polynucleotider
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK277880A (da) Fremgangsmaade til fremstilling af dipeptider
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
DK87079A (da) Fremgangsmaade til fremstilling af dialkylphospohorchloridothioter
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK231481A (da) Fremgangsmaade til fremstilling af diacetonektetogulonsyre
DK548081A (da) Fremgangsmaade til fremstilling af buspiron
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK342981A (da) Fremgangsmaade til selektiv fremstilling af m-chloraniliner
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK331381A (da) Fremgangsmaade til fremstilling af 1-klor-1-pmetoxybenzoylformaldoxim-n-metylkarbamat
DK574281A (da) Fremgangsmaade til selektiv fremstilling af m-chlorphenolder
DK574181A (da) Fremgangsmaade til selektiv fremstilling af m-chlorphenoler
DK518883D0 (da) Fremgangsmade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK385381A (da) Fremgangsmaade til fremstilling af pyraziner
DK385983A (da) Fremgangsmaade til fremstilling af 1-oxacephamer

Legal Events

Date Code Title Description
PUP Patent expired